Lysosomal targeting peptides and uses thereof

Details for Australian Patent Application No. 2009244148 (hide)

Owner ZyStor Therapeutics, Inc.

Inventors Maga, John; Lebowitz, Jonathan H.

Agent Pizzeys

Pub. Number AU-A-2009244148

PCT Pub. Number WO2009/137721

Priority 61/144,106 12.01.09 US; 61/051,336 07.05.08 US

Filing date 7 May 2009

Wipo publication date 12 November 2009

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/137721 Priority application(s): WO2009/137721

24 March 2011 Assignment before Grant

  ZyStor Therapeutics, Inc. The application has been assigned to BioMarin Pharmaceutical Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244149-Carbon nanotube-based coaxial electrical cables and wiring harness

2009244136-Low temperature irreversible thermochromic compositions